JP Lefaucheur - Pain, 2011 - ncbi.nlm.nih.gov 1. Pain. 2011 Mar 28. [Epub ahead of print] Is rTMS a therapeutic option in chronic painsyndrome? Insights from the treatment of fibromyalgia. Lefaucheur JP. Faculté de Médecine, Université Paris Est Créteil, Service de Physiologie ... Cited by 1 - Related articles - All 3 versions
DA Shoskes, D Prots, J Karns, J Horhn… - The Journal of Urology, 2011 - Elsevier Age was similar in the chronic prostatitis/chronic pelvic pain syndrome group (range 22 to 63 years, median 40) and controls (range 19 to 57, median 40). Patients had median symptom duration of 24 months (range 3 to 440), a mean Chronic Prostatitis Symptom Index score of 24.7 ± ...
MK Samplaski, J Li… - Urology, 2011 - Elsevier To evaluate the addition of an erectile dysfunction (ED) domain to the UPOINT (Urinary, Psychosocial, Organ-specific, Infection, Neurologic/systemic, and Tenderness) system in our patients. The UPOINT system classifies men with chronic prostatitis/chronic pelvic pain ... Related articles - All 3 versions
YC Lo, KK Liao, YC Lee… - Journal of Medical …, 2011 - jmedicalcasereports.com ... Machado-Joseph disease experienced severe chronicpain in both feet, cutaneous thermal change, thermal hypersensitivity, focal edema, and sweating and had a history of bone fracture. These symptoms are compatible with a diagnosis of complex regional painsyndrome. ... Cached - All 3 versions
DA Shoskes… - Urologic Clinics of North America, 2011 - Elsevier Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition with a heterogeneous origin that responds best to multimodal therapy. The bioflavonoid quercetin has antioxidant and antiinflammatory effects that have proven useful for treating this condition. Using the ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
